FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1767-1768 October 25, 2007 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Cardiac fibrosis, or scarring in the heart, has been believed for decades to be an irreversible process that leads to functional disturbances of the myocardium and ultimately results in abnormalities of cardiac contractility (systolic dysfunction) and of relaxation (diastolic dysfunction). In fact, an axiom in cardiology has been that "you cannot make a scar squeeze." A recent study by Zeisberg and colleagues¹ indicates that, like many "sure things" in medicine and science, we must reconsider whether the development of cardiac fibrosis and the untoward effects it has on cardiac function are indeed irreversible.

Cardiac fibrosis has several causes, including ischemia . . . [Full Text of this Article]

Source Information

From the Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston.

This article has been cited by other articles:

• Choi, S. S., Omenetti, A., Witek, R. P., Moylan, C. A., Syn, W.-K., Jung, Y., Yang, L., Sudan, D. L., Sicklick, J. K., Michelotti, G. A., Rojkind, M., Diehl, A. M. (2009). Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G1093-G1106 [Abstract] [Full Text]  
• Sivasankaran, S (2009). Restrictive cardiomyopathy in India: the story of a vanishing mystery. Heart 95: 9-14 [Abstract] [Full Text]